Mirae Asset Global Investments
APGE icon

Mirae Asset Global Investments’s Apogee Therapeutics APGE Stock Holding History

Mirae Asset Global Investments’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Sell
2,769
-91
-3% -$8.2K ﹤0.01% 1033
2026
Q1 		$241K Buy
2,860
+195
+7% +$14.2K ﹤0.01% 1053
2025
Q4 		$201K Buy
2,665
+882
+49% +$55.6K ﹤0.01% 1143
2025
Q3 		$70.8K Buy
1,783
+4
+0.2% +$153 ﹤0.01% 1290
2025
Q2 		$77.3K Buy
1,779
+272
+18% +$10.3K ﹤0.01% 1181
2025
Q1 		$59.9K Buy
1,507
+7
+0.5% +$271 ﹤0.01% 1210
2024
Q4 		$68.7K Sell
1,500
-128
-8% -$6.53K ﹤0.01% 1211
2024
Q3 		$94.4K Buy
1,628
+285
+21% +$13.7K ﹤0.01% 1189
2024
Q2 		$53.7K Buy
+1,343
New +$65.2K ﹤0.01% 1232

Other funds holding APGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return

Mirae Asset Global Investments's APGE Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Apogee Therapeutics (APGE) stake by 3.2% in Q2 2026, selling an estimated $8.2K and leaving 2,769 shares worth $368K. The position accounts for ﹤0.01% of the portfolio, ranked #1033.

Mirae Asset Global Investments first reported a position in APGE in Q2 2024 and has held it in 9 quarters since. 84 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Mirae Asset Global Investments held 2,769 shares of Apogee Therapeutics worth $368K as of Q2 2026.
  • Mirae Asset Global Investments sold 91 Apogee Therapeutics shares in Q2 2026, an estimated $8.2K.
  • Apogee Therapeutics made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1033 holding.
  • Mirae Asset Global Investments first reported a position in Apogee Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • 84 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.